# LLY stock has surged 25.5% over the past 52 weeks, outperforming the S&P 500 Index’s ($SPX) 24.1.

*business · news · 2026-04-09 · Barchart*

## Key points

- Eli Lilly's Q1 2026 EPS is projected to rise 126.1% year-over-year to $7.55.
- Analysts expect Eli Lilly's fiscal 2026 EPS to increase 43.5% to $34.73 from 2025.
- Eli Lilly's adjusted operating margin improved by 21.2% over the past two years.
- The average analyst price target for Eli Lilly is $1,239.50, implying a 30.6% upside.

**Companies:** Eli Lilly and Company
**Countries:** United States

[Read the full story on Barchart](https://www.barchart.com/story/news/1223162/what-to-expect-from-eli-lilly-s-next-quarterly-earnings-report)

---

Canonical: https://newsio.io/n/8319c99b-2de8-4c6e-8509-7750a0a51d16/lly-stock-has-surged-25-5-over-the-past-52-weeks-outperforming-the-sp-500-indexs
Summarized by Newsio from Barchart. https://newsio.io/how-it-works